Associate Professor Marie-Liesse Labat - Personalised Oncology division

Associate Professor Marie-Liesse Labat - Personalised Oncology division

Start Time: 
Wed, 02/09/2020 - 1:00pm
End Time: 
Wed, 02/09/2020 - 2:00pm

Targeting the tumour microenvironment to increase anti-tumour immunity in lung cancer

Join via TEAMS
Including Q&A session


Wednesday seminar hosted by Professor Peter Gibbs

Lung cancer is the leading cause of cancer death in the world. Immunotherapy that reactivates immune response against tumour cells has improved patient outcomes. However, a large majority of patients do not respond to this treatment. In this seminar Marie-Liesse will present recent work characterising immune cells in lung tumour, from pre-malignant carcinoma in situ lesions to invasive lung cancers. She will discuss discoveries by her team of key differences existing between never-smoker and smoker lung adenocarcinomas that may have important therapeutic implications.

A/Prof Marie-Liesse Asselin-Labat, Viertel Senior Medical Research Fellow, is Joint-Head of the Personalised Oncology division. She completed her PhD at the University Paris XI in 2004 and pursued post-doctoral work at the WEHI before starting her independent research program in 2011. Her work focuses on studying the effect of DNA damage on lung stem cells and the tumour micro-environment, and its implication for the initiation and progression of lung cancer. She recently came back to WEHI after spending 3 years in the US, working at University California San Diego and The Knight Cancer Institute at Oregon Health and Science University.